Stephen Cincotta
President & CEO
A respected industry leader with more than 25 years of clinical operations experience, Stephen is the founder of CRMG, and currently oversees the company's business operations and consulting network. Prior to founding the company, Stephen was the head of clinical operations at Ergo Science, a biopharmaceutical company committed to the discovery, development and commercialization of novel drugs for treating metabolic and immune system disorders. It is at Ergo where Stephen developed his passion and expertise in designing and executing metabolic disease trials. To date, he has been involved with more than 20 successful studies in this therapeutic area, including several global Phase III pivotal studies that have lead to FDA approval of a novel treatment for Type II diabetes.
If you would like to learn more about CRMG's expertise in metabolic disease, or speak to Stephen about designing your next study in this area, please fill out the contact form.